Aller au contenu

Interactions médicamenteuses

Duvelisib + Regorafenib

Gravité: Majeure

Duvelisib and Regorafenib: major interaction.

Dernière mise à jour

Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.

Le contenu clinique de cette page n'est disponible qu'en anglais.

Résumé

Duvelisib inhibits CYP3A4 and may raise regorafenib exposure, increasing hepatotoxicity, hypertension and hand-foot skin reaction. Regorafenib may in turn increase duvelisib exposure through BCRP inhibition, adding to duvelisib toxicities such as infections, diarrhea and skin reactions.

Ce que signifie cette interaction, en termes simples

Duvelisib and Regorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Duvelisib belongs to Oncology; Regorafenib belongs to Oncology.

Niveau de preuve: Moderate

Pourquoi elle survient

Duvelisib inhibits CYP3A4 metabolism of regorafenib, and regorafenib inhibits BCRP-mediated efflux of duvelisib.

Conduite à tenir

Consider avoiding the combination or reducing the regorafenib dose, with close monitoring of liver function, blood pressure and skin toxicity. Monitor for duvelisib toxicities including infection and severe diarrhea.

Questions à poser à votre pharmacien

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Réservé aux membres Pro+

Débloquer la page complète

Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Duvelisib et Regorafenib, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.

Questions fréquentes

Can I take Duvelisib with Regorafenib?

MediHelp rates the interaction as major. Duvelisib and Regorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Duvelisib inhibits CYP3A4 and may raise regorafenib exposure, increasing hepatotoxicity, hypertension and hand-foot skin reaction. Regorafenib may in turn increase duvelisib exposure through BCRP inhibition, adding to duvelisib toxicities such as infections, diarrhea and skin reactions.

How serious is the interaction between Duvelisib and Regorafenib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider avoiding the combination or reducing the regorafenib dose, with close monitoring of liver function, blood pressure and skin toxicity. Monitor for duvelisib toxicities including infection and severe diarrhea.

What other medicines interact with Regorafenib?

MediHelp also lists interactions of Regorafenib with, for example, Apalutamide, Atazanavir, Carbamazepine. The full list is on the Regorafenib page.

Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp

Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.

Parcourir de A à Z · Interactions médicamenteuses

Télécharger l'app Se connecter